Product identity
What it is
Active ingredient or category: Allopurinol
Regulatory classification: Prescription urate-lowering medication
What official sources say
- The 2020 ACR gout guideline strongly recommends allopurinol as first-line urate-lowering therapy for patients for whom that therapy is indicated.
- Starting strategy, monitoring, flare prevention, and genetic testing questions can depend on the individual.
Safety signal—not a complete warning list: Allopurinol can cause serious hypersensitivity reactions. Rash or other concerning symptoms require prompt professional instructions; do not rely on this summary for response steps. Always read the current label or source for the exact product.
Questions to take to a clinician or pharmacist
- Why is urate-lowering therapy indicated in this case?
- What starting, monitoring, flare-prevention, and target strategy does the clinician use?
- Should ancestry, kidney function, other medicines, or HLA-B*58:01 testing be discussed?
Sources reviewed
Links open the authoritative source. Product labels and guidance can change; verify the current version before relying on any summary.
Review status: This page received an editorial source check on August 3, 2026. No clinician or pharmacist is credited as independently reviewing it. Report a correction.
More in Gout
Colchicine
Colchicine is used for gout flare treatment or prevention in selected situations. It does not lower urate in the same way as long-term urate-lowering medicines.
Read source profile